SOPHiA GENETICS (SOPH) SEC Filings & 10K Form

$4.64
+0.06 (+1.31%)
(As of 05/14/2024 ET)

Recent SOPHiA GENETICS SEC Filings

DateFilerForm TypeView
05/07/2024
6:01 AM
SOPHiA GENETICS (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/19/2024
4:41 PM
SOPHiA GENETICS (Subject)
Van Well Daan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/19/2024
4:41 PM
Camblong Jurgi (Reporting)
SOPHiA GENETICS (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/19/2024
4:41 PM
SOPHiA GENETICS (Subject)
Valente Manuela (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/19/2024
4:41 PM
Menu Philippe (Reporting)
SOPHiA GENETICS (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/19/2024
4:41 PM
Muken Ross (Reporting)
SOPHiA GENETICS (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/19/2024
4:42 PM
SOPHiA GENETICS (Subject)
Xu Zhenyu (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/10/2024
7:52 PM
SOPHiA GENETICS (Subject)
Xu Zhenyu (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/10/2024
7:53 PM
Muken Ross (Reporting)
SOPHiA GENETICS (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/10/2024
7:53 PM
Menu Philippe (Reporting)
SOPHiA GENETICS (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/10/2024
7:54 PM
SOPHiA GENETICS (Subject)
Valente Manuela (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/10/2024
7:54 PM
SOPHiA GENETICS (Subject)
Van Well Daan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/10/2024
7:55 PM
Camblong Jurgi (Reporting)
SOPHiA GENETICS (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/08/2024
3:27 PM
Muken Ross (Reporting)
SOPHiA GENETICS (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/03/2024
2:42 PM
SOPHiA GENETICS (Subject)
Xu Zhenyu (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/03/2024
2:42 PM
SOPHiA GENETICS (Subject)
Valente Manuela (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/03/2024
2:43 PM
Menu Philippe (Reporting)
SOPHiA GENETICS (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/03/2024
2:43 PM
Muken Ross (Reporting)
SOPHiA GENETICS (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/03/2024
2:44 PM
Camblong Jurgi (Reporting)
SOPHiA GENETICS (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/03/2024
2:45 PM
SOPHiA GENETICS (Subject)
Van Well Daan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/08/2024
3:23 PM
HIBBS KATHY L (Reporting)
SOPHiA GENETICS (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2024
6:00 AM
SOPHiA GENETICS (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/05/2024
6:02 AM
SOPHiA GENETICS (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
02/14/2024
10:23 AM
GENERATION INVESTMENT MANAGEMENT LLP (Filed by)
SOPHiA GENETICS (Subject)
Form SC 13G/A
01/10/2024
3:59 PM
SOPHiA GENETICS (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/07/2023
6:02 AM
SOPHiA GENETICS (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/18/2023
11:12 AM
SOPHiA GENETICS (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/14/2023
7:41 AM
SOPHiA GENETICS (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/08/2023
4:17 PM
SOPHiA GENETICS (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/08/2023
6:14 AM
SOPHiA GENETICS (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/27/2023
4:29 PM
SOPHiA GENETICS (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/26/2023
9:00 AM
SOPHiA GENETICS (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/06/2023
5:00 AM
SOPHiA GENETICS (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/31/2023
5:01 AM
SOPHiA GENETICS (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/18/2023
10:23 AM
Schindel Yair Chaim (Filed by)
SOPHiA GENETICS (Subject)
Form SC 13D/A
05/17/2023
5:01 AM
SOPHiA GENETICS (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:SOPH) was last updated on 5/15/2024 by MarketBeat.com Staff

From Our Partners